Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase
- PMID: 18410085
- DOI: 10.1021/jm7012198
Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase
Abstract
Docking, scoring, molecular dynamics (MD), and the linear interaction energy (LIE) method are used here to predict binding modes and affinities for a set of 43 non-nucleoside inhibitors to HIV-1 reverse transcriptase. Starting from a crystallographic structure, the binding modes of 43 inhibitors are predicted using automated docking. The Goldscore scoring function and the LIE method are then used to determine the relative binding free energies for the inhibitors. The Goldscore scoring function does not reproduce the relative binding affinities for the inhibitors, while the standard parametrization of the LIE method reproduces the experimental binding free energies for 39 inhibitors with an R (2) = 0.70 and an unsigned average error of 0.8 kcal/mol. The present calculations provide a validation of the combination of docking, MD, and LIE as a powerful tool in structure-based drug design, and the methodology is easily scalable for attaining a higher throughput of compounds.
Similar articles
-
Predicting binding modes from free energy calculations.J Med Chem. 2008 May 8;51(9):2657-67. doi: 10.1021/jm701218j. Epub 2008 Apr 12. J Med Chem. 2008. PMID: 18410080
-
Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase.Chem Biol Drug Des. 2008 Nov;72(5):360-9. doi: 10.1111/j.1747-0285.2008.00716.x. Chem Biol Drug Des. 2008. PMID: 19012572
-
Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase.Proteins. 2002 Dec 1;49(4):529-42. doi: 10.1002/prot.10233. Proteins. 2002. PMID: 12402361
-
Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors.ChemMedChem. 2007 Aug;2(8):1141-7. doi: 10.1002/cmdc.200700054. ChemMedChem. 2007. PMID: 17477343 Review. No abstract available.
-
Inhibitors of HIV-1 reverse transcriptase.Adv Pharmacol. 2008;56:121-67. doi: 10.1016/S1054-3589(07)56005-9. Adv Pharmacol. 2008. PMID: 18086411 Review. No abstract available.
Cited by
-
Binding of BIS like and other ligands with the GSK-3β kinase: a combined docking and MM-PBSA study.J Mol Model. 2012 Feb;18(2):631-44. doi: 10.1007/s00894-011-1065-9. Epub 2011 May 11. J Mol Model. 2012. PMID: 21559963
-
Enrichment of ligands with molecular dockings and subsequent characterization for human alcohol dehydrogenase 3.Cell Mol Life Sci. 2010 Sep;67(17):3005-15. doi: 10.1007/s00018-010-0370-2. Epub 2010 Apr 20. Cell Mol Life Sci. 2010. PMID: 20405162 Free PMC article.
-
Binding free energy calculations of N-sulphonyl-glutamic acid inhibitors of MurD ligase.J Mol Model. 2009 Aug;15(8):983-96. doi: 10.1007/s00894-009-0455-8. Epub 2009 Feb 6. J Mol Model. 2009. PMID: 19198900
-
Development of a novel representation of drug 3D structures and enhancement of the TSR-based method for probing drug and target interactions.Comput Biol Chem. 2024 Oct;112:108117. doi: 10.1016/j.compbiolchem.2024.108117. Epub 2024 Jun 4. Comput Biol Chem. 2024. PMID: 38852360
-
Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.J Mol Model. 2012 Jun;18(6):2831-43. doi: 10.1007/s00894-011-1307-x. Epub 2011 Nov 30. J Mol Model. 2012. PMID: 22127612 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information